RGS9–2 Negatively Modulates l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease

Chronic l-dopa treatment of Parkinson's disease (PD) often leads to debilitating involuntary movements, termed l-dopa-induced dyskinesia (LID), mediated by dopamine (DA) receptors. RGS9–2 is a GTPase accelerating protein that inhibits DA D2 receptor-activated G proteins. Herein, we assess the f...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Neurosci
Главные авторы: Gold, Stephen J., Hoang, Chau V., Potts, Bryan W., Porras, Gregory, Pioli, Elsa, Kim, Ki Woo, Nadjar, Agnes, Qin, Chuan, LaHoste, Gerald J., Li, Qin, Bioulac, Bernard H., Waugh, Jeffrey L., Gurevich, Eugenia, Neve, Rachael L., Bezard, Erwan
Формат: Artigo
Язык:Inglês
Опубликовано: Society for Neuroscience 2007
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6673430/
https://ncbi.nlm.nih.gov/pubmed/18160641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.4223-07.2007
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы